Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

NCT04738162 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.

NCT NCT04738162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
Lead sponsor
Universität Münster
Phase
Phase 2
Overall status
Completed
Start date
September 25, 2020
Completion date
November 24, 2025
Enrollment
78 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, pediatric